NEW YORK (GenomeWeb News) – Joshua Sharfstein, who recently was appointed by President Barack Obama to serve as deputy commissioner of the US Food and Drug Administration, this morning takes over as acting FDA commissioner.

Sharfstein will hold that title while confirmation hearings are held for Margaret Hamburg, who was named by Obama to head the agency.

He takes over the interim role from Frank Torti, who has served as acting FDA commissioner since January.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.